Filing Details

Accession Number:
0001593968-20-002125
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-03 20:29:14
Reporting Period:
2020-11-02
Accepted Time:
2020-11-03 20:29:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1673772 Rapt Therapeutics Inc. RAPT Pharmaceutical Preparations (2834) 473313701
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1783296 C Karen Lam C/O Rapt Therapeutics, Inc.
561 Eccles Avenue
South San Francisco CA 94080
Vp, Finance And Controller No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-02 2,022 $28.14 12,735 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.09 to $29.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. Includes 2,022 shares acquired by the reporting person under the Issuer's 2019 Employee Stock Purchase Plan on October 30, 2020.